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Introduction 24
Cardiovascular diseases (CVD) are the leading cause of mortality globally, accounting for around 25 31 % of deaths each year (1) . In the UK CVD was the second most common cause of death in 2014, 26 responsible for 27 % of all mortalities (2) . There are several recognised risk factors for CVD 27 including raised serum low-density lipoprotein (LDL)-cholesterol and triacylglycerol (TAG), low 28 serum high-density lipoprotein (HDL)-cholesterol, elevated blood pressure, diabetes and obesity 29 many of which can be modified by the lifestyle choices, including diet (3) . Epidemiological data 30 from the 1970's indicated that coronary heart disease (CHD) rates were higher in countries with low 31 fruit and vegetable consumption (4) . This has been supported by a number of more recent studies that 32 have shown that dietary patterns rich in fruit and vegetables are associated with reduced rates of 33 CHD, stroke and CVD mortality (5; 6; 7; 8; 9; 10) . Some researchers have attempted to identify the types 34 of fruits and vegetables responsible for the reduced risk of CVD. Joshipura et al in 2001 showed 35 that people in the highest quintile of fruit and vegetable intake had a 20% lower relative risk (RR) 36
for CHD compared with those in the lowest quintile of intake. In addition, each 1 serving per day 37 increase in fruit and vegetable intake was associated with a 4 % lower risk of CHD. They also 38
found that vitamin C-rich fruits (6 % lower RR per 1 serving/day increase) and particularly green 39 leafy vegetables (23 % lower RR per 1 serving/day increase) had the largest protective effects (5) .
40
Fruits and vegetables are a rich source of phytochemicals such a flavonoids and dietary nitrates, 41 which have been shown to independently exert a number of health effects and could be responsible, 42 at least in part, for the apparent protective effects of fruit and vegetable consumption. The aim of 43 this review is to provide a brief overview of evidence related to the effects of flavonoids and dietary 44 nitrates on cardiovascular health with particular reference to vascular and platelet function. 45 
46

Dietary flavonoids 47
The main categories of phytochemicals are polyphenols, which include flavonoids, terpenoids, 48 nitrogen-containing alkaloids and sulphur-containing compounds. Flavonoids are produced by 49 plants as secondary metabolites and have biological roles in plant pigmentation, flavour, growth, 50 reproduction, predator and pathogen resistance (11) . They are present in a variety of foods including 51 vegetables, fruits, nuts, grains, red wine and chocolate, in concentrations that vary due to a number 52 of factors, including environmental stress, such as UV exposure (12) . Flavonoids consist of two 53 benzene rings linked by a 3-carbon chain (C6-C3-C6) as shown in Figure 1 . The flavonoid classes 54 differ due to the C ring structural differences, number of phenolic hydroxyl groups and their 55 substitutions, and are commonly divided into seven structural subclasses namely: isoflavones, 56 flavanols or catechins, flavanonols, flavonols, flavanones, flavones, anthocyanins andanthocyanidins (13) (Figure 2) . The small structural variations between subclasses are related to 58 considerable differences in biological functions. 59
Absorption and Metabolism of flavonoids 61
Flavonoids are commonly found in the diet as conjugated esters, glycosides or polymers, which 62 have limited bioavailability, requiring intestinal enzyme hydrolysis or colonic microbiota 63 fermentation before absorption into the circulation. Aglycones formed in the intestine by cleavage 64 of flavonoid side chains can enter the epithelial cell by passive diffusion (14) . However polar 65 glucosides can be actively transported into epithelial cells via the sodium-dependent glucose 66 transporter 1 (SGLUT1), where they are hydrolysed by intracellular enzymes to the aglycone (15) .
67
The importance of the latter absorption route is unclear, but glycosylated flavonoids and aglycones 68 have been shown to inhibit the SGLUT1 transporter, potentially reducing dietary glucose 69 absorption (16) . Before transport to the circulation, the aglycones also undergo further metabolism 70 (Phase II) and conjugation including glucuronidation, methylation or sulfation. Efflux of the 71 metabolites back into the intestine also occurs via transporters including multidrug resistance 72 protein and P-glycoprotein and the glucose transporter GLUT2 (17) . Further Phase II metabolism 73 occurs in the liver via portal vein transportation and further recycling into the intestinal lumen via 74 the enterohepatic recirculation in bile (18) . Some flavonoids, particularly polyphenol sugar 75 conjugates, pass unabsorbed into the colon and are associated with marked modulation of the 76 colonic gut microbiota (19) and the production of principally small phenolic acid and aromatic 77 catabolites, which are subsequently absorbed into the circulation (20) . These metabolites can be 78 subjected to further metabolism in the liver before they are efficiently excreted in the urine in 79 quantities far higher than those that entered the circulation via the intestine (21) . Due to the extensive 80 metabolism and rapid excretion, plasma concentrations do not reflect quantitative absorption and 81 total urinary metabolite excretion can be a more valuable biomarker of intake. Evidence for tissue 82 accumulation of polyphenols and their metabolites is very limited and while this can't be ruled out, 83 it is believed that frequent ingestion of flavonoid-rich foods is required to maintain constant 84 circulating levels (see review (22) ). Detailed studies using stable isotopes have allowed the 85 determination of metabolic pathways of certain polyphenol subclasses. Anthocyanins, found in 86 foods such as berries, are reported to have low bioavailability, but recent data have shown they are 87 extensively metabolised to a diverse range of metabolites, which has highlighted a previous 88 underestimation of anthocyanin absorption and metabolism (23) . 89 fruit and vegetable consumption and cardiovascular disease mortality (24; 25) . Yet it is difficult to 93 identify the specific mediator(s) of health due to the numerous potential bioactive compounds 94 present in fruits and vegetables. Observational studies suggest that intakes of flavonoids are 95 associated with a decreased risk of CVD, although the findings are not entirely consistent, because 96 of variation in population studied, dose and specific flavonoid consumed. Data from a large post-97 menopausal cohort identified a negative association between flavonoid-rich diets and CVD 98 mortality (26) . Further evidence showed intakes of flavanol-and procyanidin-rich foods were 99 associated with decreased risk of chronic non-communicable diseases particularly CVD (27; 28) . In 100
2005, Arts and Hollman collated data from 15 prospective cohort studies, of these 13 provided 101 evidence for a positive association between dietary flavanols, procyanidins, flavones and flavanones 102
and CVD health, with a reduction of CVD mortality of approximately 65 % (29) . Systematic 103 reviews (30; 31; 32) that have focused on flavonol intake have reported inconsistent findings including 104 an inverse association between high flavonol intake and CHD or stroke mortality (31; 32) compared 105 with no association between flavonol intake and CHD risk (30) . However, a more recent 106 comprehensive systematic review and meta-analysis of 14 studies identified that intakes of 107 anthocyanidins, proanthocyanidins, flavones, flavanones and flavan-3-ols were associated with 108 lower CVD RR of 11 %, 10 %, 12 %, 12 % and 13 % respectively when comparing the highest and 109 lowest categories of intake; with a 5 % lower RR for CVD for every 10mg/d increment in flavonol 110 intake (33) .
112
An inverse association between flavanol intake and CVD mortality was initially identified in the 113 Iowa women health study, which followed 34,489 women, free of CVD at study inclusion (34) while, 114 a subsequent follow-up found no association between reduced CVD risk and flavanol intake, 115 instead an association with procyanidin intake (26) . These seemingly contrasting findings were due to 116 the different ways the data from chocolate and seeded grapes were categorized in the dietary 117 assessment, and emphasises the importance of standardisation of dietary assessment, and the 118 possible benefits of using biomarkers of intake. Evidence from prospective cohort studies generally 119 supports the hypothesis that a greater intake of dietary flavonoids is associated with a lower risk of 120 CVD, although there are inconsistencies in potential benefit. Further supportive evidence from 121 well-performed randomly controlled dietary intervention studies is required to establish a direct 122 relationship between different flavonoid sub-groups and CVD risk. in endothelial function contribute to the pathogenesis and clinical expression of CVD (35) . Many 127 factors impact adversely on the endothelium, these include diabetes mellitus, smoking, physical 128 inactivity, aging, hypertension, systemic inflammation, dyslipidaemia and insulin resistance, with 129 diet being key in modulating endothelial function (36; 37) . Prospective cohort studies have supported 130 the association between endothelial function and an increased risk of CVD events and have 131 identified the latter as a valuable holistic surrogate marker of CVD risk (38; 39) . Endothelial 132 dysfunction has been associated with the development of atherosclerosis and CVD (40) and is most 133 commonly measured in the brachial artery by flow mediated dilatation (FMD), which uses non-134 invasive ultrasound before and after increasing shear stress by reactive hyperaemia, with the degree 135 of dilation reflecting arterial NO release. Another commonly used technique is laser Doppler 136 imaging with iontophoresis (LDI), which measures the endothelial function of the peripheral 137 microcirculation. The degree of endothelial dysfunction occurring in the microcirculation has been 138
shown to be proportional to that occurring in the coronary arteries (41) . This technique measures the 139 response of cutaneous blood vessels to transdermal delivery of two contrasting vasoactive agents: 140 acetylcholine (endothelium-dependent vasodilator) and sodium nitroprusside (endothelium-141 independent vasodilator) by iontophoresis. A reduced local vasodilatory response to acetylcholine is 142 associated with endothelial dysfunction (42) . 143
144
Consumption of fruits rich in anthocyanins and proanthocyanidins in the form of purple grape juice 145 or grape seed extract (for between 14-28 days) significantly increased FMD in volunteers with 146 angiographically documented CHD or above average vascular risk (43) . Furthermore, consumption of 147 pomegranate, containing tannins and anthocyanins, for a period of 90 days to 3 years resulted in 148 improvements in carotid intermedia thickness (CIMT), a measure of the extent of atherosclerosis in 149 the carotid artery, in those with increased CVD risk (43) . The FLAVURS study investigated the dose-150 dependent effect (+2, +4 and +6 additional portions/d) of flavonoid-rich and flavonoid-poor fruits 151
and vegetables compared to habitual diet, on microvascular reactivity, determined by LDI, and 152 other CVD risk markers. After two additional portions of flavonoid-rich fruits and vegetables, 153 equivalent to an estimated increase in total dietary flavonoids from 36  5 to 140  14 mg/d (44) , a 154 significant increase in endothelium-dependent microvascular reactivity was observed in men. In 155 addition, reduced C-reactive protein, E-selectin and vascular cell adhesion molecule, and increased 156 plasma NOx was observed with four additional flavonoid-rich portions, compared to the control and 157 low-flavonoid intervention (45) . This data supports vascular improvements reported in a previous 158 study investigating a similar single dose of flavonoid-rich foods (46) . Identification of the specific 159 flavonoid bioactive is not possible in studies that include a variety of foods, yet these datademonstrate that dietary relevant doses of total flavonoids can contribute to vascular health and 161 could be considered as useful strategies for CVD risk factor reduction. 162
163
The majority of the population is in a postprandial state for most of the day and it is recognized that 164 acute physiological responses to meals are a major contributor to overall CVD risk. Flavonoid-rich 165 foods have been implicated in modulating postprandial responses. For example blueberries are a 166 rich source of flavonoids, particularly anthocyanin, flavanol oligomer, and chlorogenic acid (47) .
167
Acute improvements in vascular function, measured by FMD, were observed in healthy men in a 168 time-and dose-dependent manner (up to a concentration of 766mg total polyphenols) (48) with little 169 observed effect of processing (47) . These beneficial effects on postprandial vascular reactivity are not 170 confined to blueberries, as a mixed fruit puree containing, 457 mg (-)-epicatechin increased 171 microvascular reactivity and plasma NOx (49) . Although the fruit puree contained varied flavonoids, 172 the potential vascular benefits of (-)-epicatechin is supported by a meta-analysis of six randomly 173 controlled trials which found that 70-177 mg (-)-epicatechin, from cocoa or chocolate sources 174 significantly increased postprandial FMD by 3.99 % at 90-149 min post ingestion (50) . These data 175
indicate that different classes of flavonoids in the form of foods can significantly improve 176 postprandial vascular function and possible CVD risk. 177
Flavanols, as a subgroup of flavonoids, have been extensively studied and increasing evidence has 179
shown that higher intake of flavanol-rich foods improve arterial function in numerous groups 180 including those at risk for CVD, with established CVD (51) and more recently healthy young and 181 aging individuals (52) . The mechanisms of action are not totally understood, but causality between 182 intake and an improvement in arterial function has been demonstrated (53) . The important dietary 183 flavonol, (-)-epicatechin, is naturally present is high concentrations in cocoa, apples and tea and a 184 number of systematic reviews and meta-analyses, including a recent study of 42 randomised 185 controlled human dietary intervention studies on supplemental and flavan-3-ols-rich chocolate and 186 cocoa, reported significant acute and chronic (up to 18 weeks) dose-dependent cardiovascular 187 benefits, including recovery of endothelial function, lowering of blood pressure and some 188 improvements in insulin sensitivity and serum lipids (50; 54; 55) . Furthermore green and black tea (rich 189 in (-)-epicatechin) was also reported to reduce blood pressure and LDL-cholesterol in a systematic 190 review and meta-analysis of a small number of studies, but these findings need confirmation in 191 long-term trials, with low risk of bias (56) . The extensive studies into the vascular effects of (-)-192 epicatechin and their impact on other CVD risk markers has prompted some to propose specific 193 dietary recommendation for these flanonoids and a broader recommendation on flavanol-rich fruitsand vegetables for CVD risk reduction, although further evidence may be required before specific 195 recommendations are considered. (57) 
Possible mechanisms of flavonoids and vascular effects 198
Despite the high antioxidant potential of a number of classes of flavonoids, there is limited evidence 199 to support this mechanism of action due to the low plasma concentrations of flavonoids compared 200 with other endogenous or exogenous antioxidants (58) . Many of the vascular effects of flavonoids 201 have been associated with molecular signalling cascades and related regulation of cellular function. 202
One of the potential mechanisms of action is the association between flavonoid, particularly (-)-203 epicatechin, and prolonged, augmented nitric oxide (NO) synthesis, the primary modulator of 204 vascular dilation (53) . NO production from L-arginine is regulated by three nitric oxide synthase 205 (NOS) enzymes: endothelial NOS (eNOS), neuronal NOS (nNOS) and inducible NOS (iNOS) with 206 lower production and/or availability of NO as the main effect on endothelial dysfunction. Several in 207 vitro and human studies have reported potent vasorelaxant activity of certain flavonoids related to 208 activation of eNOS (53; 59) . A common polymorphism in the eNOS gene is the Glu298Asp single-209 nucleotide polymorphism that modifies its coding sequence, replacing a glutamate residue at 210 position 298 with an aspartate residue. This polymorphism has been linked to increased risk of 211 cardiovascular events putatively through reduced NO production by eNOS (60; 61) . Interestingly, in a 212 small acute randomized control study a significant genotype interaction with endothelium-213 dependent microvascular dilation was observed after consumption of fruit and vegetable puree 214 containing 456 mg (-)-epicatichin. Wild-type, GG, participants (non-risk group) showed an 215 increased endothelial vasodilation at 180 min compared to control, with no effect in T allele 216 carriers. This supports the importance of (-)-epicatichin in eNOS activation and NO availability, 217 with little vascular effect of (-)-epicatichin in those with impaired eNOS function. This nutrient-218 gene interaction may explain in part, the large variation in individual vascular responses to 219 flavonoid consumption, but requires further confirmatory studies (62) . 220
221
Flavonoids have also been reported to modulate xanthine oxidase activity, resulting in decreased 222 oxidative injury and consequential increased NO (63) . The vascular effects induced by phenolics may 223 also be mediated by the inhibition of Ca2+ channels and/or the blockage of the protein kinase C-224 mediated contractile mechanism, as has been observed for caffeic acid phenyl ester and sodium 225 ferulate, respectively (64) . Furthermore, benefits may be mechanistically linked to the actions of 226 circulating phenolic metabolites on inhibition of neutrophil nicotinamide adenine dinucleotide 227 phosphate (NADPH) oxidase activity, which prevents NO degradation and increases its 228 availability (48) . More recently a possible role of flavonoid promotion of endothelium-deriveddilation of the vascular smooth muscle cell has been identified (65) . In summary there are multiple 231 potential mechanisms by which flavonoids and their metabolites can modulate vascular function (66) 232 and these may act in an additive or synergistic manner. It is evident that dietary relevant doses of 233
Flavonoids and platelet aggregation 237
Platelets are small nucleated cell fragments that are produced by megakaryocytes in the bone 238 marrow (67; 68) and play a critical role in haemostasis through formation of aggregates over arterial 239 wall injuries (69) . When platelet activation becomes impaired, thrombosis can occur, a 240 pathophysiological condition which can lead to blockage of coronary arteries or impaired blood 241 supply to the brain, leading to events such as myocardial infarction (MI) or stroke (70) .
Many studies 242
have previously shown the ability of flavonoids to inhibit platelet function (71; 72; 73) . Quercetin is 243 found in many foods such as apples, onions, tea and wine, and present in significant quantities in 244 many diets (74) . Further understanding of how quercetin modulates platelet function is of relevance 245 to establish a mechanistic link between flavonols and CVD risk. 246
Hubbard et al. (75) observed a significant inhibition of ex vivo platelet aggregation after ingestion 247 of quercetin-4'-O- -D-glucoside at a dose of 150 mg and 300 mg, with peak quercetin metabolite 248 concentrations of 4.66 M and 9.72 M respectively. This data was supported by a further small 249 human study which reported at peak plasma quercetin metabolite concentrations of 2.59 M and 250 significant inhibition of ex vivo collagen-stimulated platelet aggregation 60 and 240 min after 251 consumption of a high-quercetin onion soup rich in quercetin glucosides (68.8 mg total quercetin) 252 compared with a matched low quercetin onion control (4.1 mg total quercetin) (76) .
Inhibition of 253
Spleen Tyrosine Kinase (SYK) and Phospholipase C2 (PLC2), two key platelet proteins involved 254 with the collagen-stimulated signalling pathway were also observed, and confirms this as one 255 potential mechanism of action. These data are in agreement with previous in vitro studies displaying 256 the ability of quercetin to inhibit collagen, ADP and thrombin-stimulated platelet aggregation, as 257 well as inhibiting collagen-stimulated Mitogen-Activated Protein (MAP) kinases and 258
Phosphoinositide 3-kinase (PI3K) phosphorylation (77; 78) . 259
Flavonoids undergo significant endogenous metabolism and it is important to determine the 260 bioactivity of metabolites as well as the aglycones by understanding structure-activity relationships 261 and how functional groups affect platelet function. Anti-platelet effects of tamarixetin, quercetin-3-262 sulphate and quercetin-3-glucuronide, as well as the structurally distinct flavonoids apigenin andsignificantly inhibited collagen-stimulated platelet aggregation and 5-HT secretion with similar 265 potency, and logIC50 values for inhibition of aggregation of -5.17 (0.04) and -5.31 (0.04), 266 respectively (79) . Flavones (such as apigenin) are characterized by a non-hydroxylated C-ring, 267 whereas the C-ring of flavonols (e.g. quercetin) contain a C-3 hydroxyl group (Figure 1) . Catechin 268 was less effective, with an inhibitory potency two orders of magnitude lower than quercetin, 269 suggesting that in vivo, metabolites of quercetin and apigenin may be more relevant in the inhibition 270 of platelet function. Flavan-3-ols such as catechin possess a non-planar, C-3 hydroxylated C ring, 271 which is not substituted with a C-4 carbonyl group (as is found in flavonols). Quercetin-3-sulphate 272 and tamarixetin (a methylated quercetin metabolite) were less potent than quercetin, with a 273 reduction from high to moderate potency upon addition of a C-4' methyl or C-3'-sulphate group, 274 but at concentrations above 20 M, all achieved substantial inhibition of platelet aggregation and 5-275 HT release. Quercetin-3-glucuronide caused much lower levels of inhibition, providing evidence for 276 reduced potency upon glucuronidation of the C ring. Jasuja et. al have shown quercetin-3-277 glucuronide to potently inhibit protein disulphide isomerase (PDI), an oxidoreductase important in 278 thrombus formation (80) . X-ray crystallographic analyses of flavonoid-kinase complexes have shown 279 that flavonoid ring systems and the hydroxyl groups are important features for kinase binding (81) (82) 280 supporting the evidence for structure-specific effects on platelet function. Taken together, this 281 evidence shows the importance of understanding the structural differences of flavonoids, and how 282 specific functional groups on polyphenols can lead to enhanced or reduced effects in different 283 stages of haemostasis and thrombosis. This evidence may also facilitate the design of small-284 molecular inhibitors and inform specific dietary advice. 285
286
In summary, flavonoids are generally poorly absorbed and substantially metabolised to aid rapid 287 elimination. Many flavonoid subgroups reach the colon in their native state, and are fermented by 288 the microbiota, which produces small phenolic metabolites with potential bioactivity after 289 absorption. CVD risk reduction from high fruit and vegetable intake may be due, in part, to benefits 290 from flavonoid ingestion. In particular, (-)-epicatechin, a key flavanol, has been causally linked 291 with increased arterial endothelial-dependent dilation measured by FMD, with a putative increase in 292 NO bioavailability. Other potential mechanisms of action include modulation of NADPH oxidase 293 activity and reduction of NO degradation. Furthermore, flavonoids, particularly quercetin and its 294 metabolites, reduce in vitro and ex vivo platelet function, possibly via inhibiting phosphorylation in 295 cell signalling cascades. Further research will be required to determine the biological effects of 296 flavonoid subgroups in vivo, and the minimal effective dose of these compounds before it is 297 possible to make any specific dietary recommendations. 298
Inorganic nitrate and nitrite 301
Inorganic nitrate and nitrite were previously considered largely inactive by products of the 302 oxidation of NO endogenously. However, emerging evidence suggest these anions are important 303 storage forms of NO, which can be reduced to bioactive NO under certain conditions. Nitrate is 304 particularly abundant in vegetables such as beetroot and green leafy varieties (spinach, lettuce, 305 rocket) where it is absorbed from the soil and transported to the leaf where it accumulates. Nitrate is 306 important for plant function and is the main growth-limiting factor. In UK diets, estimates from 307 1997 suggest that the average nitrate intake is approximately 52 mg/day, with vegetables being the 308 main source of nitrate, contributing around 70 % of daily intakes with the remaining nitrate derived 309 from drinking water (83) . 310
The consumption of inorganic nitrate either from dietary or supplemental sources have been 311
shown to exert a number of important vascular effects such as blood pressure lowering, protection 312 against ischemia-reperfusion injury, inhibiting platelet aggregation, preserving or improving 313 endothelial dysfunction and enhancing exercise performance (84) .
315
The nitrate-nitrite-NO pathway 316
The continuous generation of NO from L-arginine by the enzymatic action of eNOS in the presence 317 of oxygen within endothelial cells is important for maintenance of vascular homeostasis. Indeed 318 reduced production or bioavailability of NO is associated with a number of cardiovascular and 319 metabolic disorders (85) . The nitrate-nitrite-NO pathway is a NOS and oxygen independent pathway 320 for the generation of bioactive NO, and is an important alternative pathway for NO production, 321 particularly during periods of hypoxia (86) . Ingested nitrate, obtained mainly from green leafy 322 vegetables and beetroot, is readily absorbed in the upper part of the gastrointestinal tract where it 323 mixes with NO produced from NOS (87) . 324
325
Ingested nitrate peaks after approximately 1 hour (88) and remains elevated for up to 5-6 hours post 326 ingestion. The majority of ingested nitrate (65-75 %) is excreted in urine with a very small 327 proportion of nitrate (<1 %) reaching the large bowl, which is excreted in the faeces (89) . The 328 remaining nitrate is reabsorbed by the salivary glands and concentrated up to 20-fold, reaching 329 concentrations of 10 mM in the saliva (90) . Salivary nitrate is converted to nitrite via a two-electron 330 reduction, a reaction that mammalian cells are unable to perform, during anaerobic respiration by 331 nitrate reductases produced by facultative and obligate anaerobic commensal oral bacteria (86; 91) . 332
The importance of oral bacteria in the nitrate-nitrite-NO pathway has been demonstrated in a 333 number of studies (88; 92; 93) . When the nitrite rich saliva reaches the acidic environment of thestomach some of it reacts to form nitrous acid, which further decomposes to NO and other reactive 335 nitrogen oxides (94) . The remaining nitrite (approximately 95 %) is absorbed into the circulation (95) where it forms NO via the action of a number of different nitrite reductases, which have selective 337 activity under oxygen/hypoxic/ischaemic conditions. These include haemoglobin (96) , myoglobin (97) , 338 cytoglobin and neuroglobin (98) , xanthine oxidoreductase (99) , aldehyde oxidase (100) , aldehyde 339 dehydrogenase type 2 (101) , eNOS (99) , cytochrome P450 (102) and the mitochondrial electron transport 340 chain (103) . It is likely that the majority of the cardioprotective effects observed from dietary nitrate 341 consumption are via the conversion of nitrite to NO in blood and tissues. 342
Vascular effects of dietary nitrate and nitrite 344
Beneficial effects of nitrate consumption on vascular related function was first identified by Larsen 345 et al. (104) , who showed that supplementation of healthy humans for three days with sodium nitrate 346 reduced blood pressure. Since then, a number of studies have shown that dietary nitrate-rich 347 vegetable sources such as beetroot juice, spinach, rocket and breads also lower blood pressure and 348 vascular function in healthy subjects (88; 105; 106; 107) . 349
350
Endothelial dysfunction 351
A hallmark of endothelial dysfunction is the reduced bioavailability of NO, either through reduced 352 eNOS activity or expression, or via increased NO consumption by free radicals and reactive oxygen 353 species (108) as discussed above. It has been shown that consumption of 500 mL beetroot juice 354 containing 23 mmol nitrate reversed the deleterious effects of a mild ischaemia-reperfusion injury 355 to the forearms of healthy subjects and preserved the FMD response, whereas the response was 356 reduced by 60 % in the control subjects (88; 93) . Hobbs et al. (105) found that consumption of bread 357 enriched with beetroot increased endothelium-independent blood flow in healthy subjects measured 358 by LDI. In healthy overweight and slightly obese subjects consumption of 140 mL beetroot juice 359 (500 mg nitrate) or control alongside a mixed meal (57 g fat) attenuated postprandial impairment of 360 FMD (109) . More recently daily consumption of dietary nitrate in the form of beetroot juice over a 6-361 week period resulted in a 1.1 % increase in the FMD response compared with a 0.3 % worsening in 362 the control group (110) . However, not all studies have found a beneficial effect of dietary nitrate on 363 endothelial function, with no effects of 250 mL beetroot juice (7.5 mmol nitrate) on FMD response 364 in patients with type 2 diabetes (111) . Furthermore, supplemental potassium nitrate consumption (8 365 mmol nitrate) did not affect FMD response in healthy subjects, although a significant reduction (0.3 366 m/s) in pulse wave velocity and SBP (4 mm Hg) at 3 h compared with the potassium chloride 367 control was reported. This suggests that although inorganic nitrate did not alter endothelial function, 368 it did appear to increase blood flow in combination with reductions in BP.
Organic and inorganic nitrate/nitrites are both effective in vascular health, yet it has been proposed 371 that inorganic dietary nitrate may be a more appropriate choice for vascular modulation than 372 organic nitrate supplements (112) . The enterosalivary circulation is key for the effects of inorganic 373 nitrate and prevents a sudden effect, or toxic circulating concentrations of nitrite, in addition to 374 prolonging the vascular effects. In contrast, supplemental organic nitrate, which does not require the 375 enterosalivary circulation for absorption, has rapid pharmacodynamic responses, causing potent 376 acute effects, immediate vasodilation, and in chronic use considerably limited by the development 377 of tolerance and endothelial dysfunction. The more subtle and controlled effects of inorganic nitrate 378 may compensate for diminished endothelial function, and also has no reported tolerance. Therefore, 379
with the increasing recognition of the limitations of organic nitrate supplementation, and continuing 380 discovery of beneficial effects of inorganic nitrate/nitrite, dietary inorganic forms may prove to be 381 the optimum strategy for vascular health (112) . 382
eNOS Glu298Asp polymorphism and nitrate interactions 384
Variation in response to nitrates could be due to genetic polymorphisms. Healthy men 385 retrospectively genotyped for the Glu298Asp polymorphism (7 GG and 7 T carriers), showed a 386 differential postprandial BP response after consumption of beetroot-enriched bread compared with 387 the control bread. A significantly lower DBP in the T carriers was observed with a concomitant 388 tendency for higher plasma NOx concentration. Despite the small study size these data suggests that 389 carriers of the T allele, which limits endogenous NO production from endothelial eNOS (113) , were 390 more responsive to dietary nitrate. Cross-talk between NOS-dependent pathway and the nitrate-391 nitrite-NO pathway in control of vascular NO homeostasis could be a possible explanation for these 392 observations (114) , although future suitably powered studies are needed to confirm these findings. 393
This nutrient-gene interaction is in contrast to that demonstrated for the same eNOS polymorphism 394 and dietary flavonoids (described above), and confirms the differential proposed mechanisms by 395 which flavonoids and nitrates impact on NO availability and vascular function. 396
Blood pressure 398
Dietary nitrate has been shown to reduced SBP and/or DBP, and increase circulating nitrate/nitrite 399 (see review (115) ). These findings are supported by more recent acute and chronic studies conducted 400 in healthy younger populations (Table 1) . A recent meta-analysis of four randomised clinical trials 401 in older adults (55-76 y) revealed that consumption of beetroot juice did not have a significant 402 effect on blood pressure. However, consumption of beetroot juice containing 9.6 mmol/d for 3 days 403 (116) , or 4.8-6.4 mmol nitrate/L for three weeks (117) by older adults (60-70 y) significantly lowered 404 findings highlight the need for further studies to determine effects in older population groups. 406
It was concluded from data collated from eight studies conducted in patient groups that dietary 407 nitrate may help to reduce blood pressure in hypertensive subjects, but not in patients with type 2 408 diabetes, although only one study could be found in the latter population group (118) . Furthermore, 409 minimal effects were reported in obese insulin resistant individuals (119) , and those with chronic 410 obstructive pulmonary disease despite relatively high doses of dietary nitrate (13.5 mmol/d and 9.6 411 mmol/d, respectively), although the intervention period was limited (2-3 days) (120; 121) . In contrast 412 consumption of beetroot juice (7.6 mmol/d) by 15 individuals with chronic obstructive pulmonary 413 disease significantly lowered DBP by 8.2 mmHg (P=0.019) (122) . Additional studies are required to 414 confirm these findings. 415
416
Platelet aggregation 417
Dietary and supplemental nitrate have been reported to significantly reduce platelet aggregation in 418 healthy individuals (88; 110; 123) . However, a lack of effect was observed in women from one study. A 419 proposed explanation for this gender difference was reduced soluble guanylyl cyclase (sGC) 420 activity (123) , a hypothesis supported by studies in mice (124; 125) , although further conformational 421 studies are required. 422
423
Metabolic function 424
The consumption of sodium nitrate by eNOS deficient mice reversed features of the metabolic 425 syndrome including improvements in blood pressure, bodyweight, abdominal fat accumulation, 426 circulating TAG levels and glucose homeostasis (126) . The improvements in glucose homeostasis by 427 inorganic nitrate have been shown in a number of other mouse studies (127; 128; 129; 130) . For example, 428
Khalifi et al. (130) examined the effects of dietary nitrate in glucose tolerance and lipid profile in type 429 2 diabetic rats, and found that supplementation of drinking water with 100 mg/L sodium nitrate 430 prevented an increase in systolic blood pressure and serum glucose, improved glucose tolerance and 431 restored dyslipidaemia in an animal model of hyperglycaemia. A possible mechanism for the 432 beneficial effects of nitrate on glucose homeostasis may be the nitrite-mediated induction of 433 GLUT4 translocation (131) , which enhances cellular uptake of glucose. More recent data has also 434 shown that dietary nitrate may increase browning of white adipose tissue, which may have 435 antiobesity and antidiabetic effects (132) . Yet there are few studies that have investigated the effects 436 of dietary nitrate on glucose homeostasis in humans. Gilchrist et al. (111) found that consumption if 437 by the hyperinsulinaemic isoglycaemic clamp method. In support of this Cermark et al. (133) found 440 in the stomach is enhanced by increasing nitrite concentrations, lower stomach pH and the presence 462 of vitamin C or polyphenols (134; 135; 136) . Bondonno et al. (106) investigated the independent and 463 additive effects of consumption of flavonoid-rich apples and nitrate-rich spinach. They found that 464 the combination of nitrate and flavonoids did not result in additive effects on NO status, endothelial 465 function or blood pressure, although independent effects of flavonoid-rich apples and nitrate-rich 466 spinach on these outcomes were reported. More recently, Rodriguez-Mateos et al. (137) investigated 467 interactions between cocoa flavanols and nitrate, and demonstrated additive effects on FMD 468 response when cocoa flavanols and nitrate were consumed at low doses in combination. In addition, 469 cocoa flavonoids enhanced nitrate related gastric NO formation, supporting previous studies and 470
suggests nutrient-nutrient interactions may modulate vascular function. Thus there is some evidence 471 to suggest that nitrates and flavonoids, when consumed in combination, may exert additive effects 472 on cardiovascular health, but due to the extremely limited data, confirmatory studies are required.
Conclusions 477
There is an increasing body of evidence to suggest that dietary flavonoids, particularly flavonols 478 
